At Janssen Oncology, we’re shaping the future of cancer treatment. And in the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health.
Janssen Oncology is part of Janssen Biotech, Inc. and the Janssen Pharmaceutical Companies of Johnson & Johnson. As a leading pharmaceutical company in the United States, Janssen focuses its innovation on some of the most devastating diseases and the most complex medical challenges of our time across five therapeutic areas. In addition to Oncology, this includes Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, and Neuroscience.
Janssen’s commitment to providing safe and effective medicines, as well as the services and support that contribute to healthy outcomes, calls for the best science, the most creative minds and an openness to collaborate with researchers, governments and patient organizations at every stage – from early discovery to market access and patient education.
For more information, visit www.janssen.com/us. Follow us on Twitter at www.twitter.com/JanssenUS.